Gyrus Capital to acquire majority stake in Katalist Group
Gyrus Capital to acquire a majority stake in Katalist Group to build out a global software integration platform enhancing the digital transformation of food and pharma distribution.
Gyrus Capital, along with the founders and management, has agreed to acquire the Katalist Group, one of the leading providers of software implementation and consulting services for global food wholesalers & retailers and pharmacy companies.
The Katalist Group helps clients transform and digitalise their businesses using a range of IT and software solutions and applications. Katalist has an unmatched track record in deploying solutions to retail clients, particularly in the pharma and food sectors.
The Katalist Group employs more than 300 FTEs and has operations in Europe, Asia, North and South America. Katalist’s services address the increasing needs of retailers, wholesalers and distributors of food and pharma products to digitalise and optimise supply chains of perishable/sensitive goods and regulated medical products. Leveraging the industry know-how and technical expertise of its group companies, Katalist will pursue growth through the acquisition and integration of specialist software implementors servicing common verticals, notably food retail, pharmacies and the respective wholesale and supply chains.
Cédric Perlet, Partner at Gyrus Capital said “The team at Katalist has profound industry expertise and has built a business with sustainable growth over the last 10 years. We are delighted to partner with them and will support them to accelerate further on this positive trajectory. We will be leveraging our sector experience and network in food and pharma distribution to acquire and integrate further software integrators into the Katalist group to fully realise the potential of Katalist and its proprietary software platform.”
Guy Semmens, Managing Partner at Gyrus Capital added “Bringing food and medicines safely and efficiently to customers while reducing waste and improving product safety is a core theme within both our sustainability and healthcare strategies.”
Gyrus Capital is a European investment firm dedicated to transformational investments in the healthcare and sustainability sectors. Based in Geneva, Switzerland, Gyrus invests in businesses that address structural needs of society and the environment – and that are positioned for long-term, sustainable growth. Gyrus has a focus on complex transactions, with particular focus on corporate carve outs in the €50 million to €500 million range. A renowned group of experienced partners and industry experts support Gyrus in its active investment and value-creation approach in close partnership with entrepreneurs and managers.
To learn more, please visit www.gyruscapital.com